Purchase of Magnafodipir Trisodium (x200 units)
- University of Edinburgh
- Scotland
- Invited to quote
- Start not published to 12 May 2026
Procurement of 200 units of Magnafodipir Trisodium, a specific Magnetic Resonance Imaging (MRI) contrast agent required for ongoing clinical studies. This is a sole-source supply contract for clinical-grade material suitable for human use, as required by the Institute for Neuroscience and Cardiovascular Disease.
- Awarded value
- £66k
- As published
- Published
- 25 May 2026
- Contract length
- Not stated
- Ends 12 May 2026